WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Modest Weight Loss Plus Few GI Upsets With Amylin Injectable

Ideal weight-loss drug for primary care, patients without obesity-related complications

Raccontata damedpagetoday.comhealio.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
medpagetoday.comStai leggendo1 g fa

Modest Weight Loss Plus Few GI Upsets With Amylin Injectable

Ideal weight-loss drug for primary care, patients without obesity-related complications

originale
healio.com1 g fa

Petrelintide, a novel amylin analog, induces 10% weight loss, very well tolerated

NEW ORLEANS — Weekly petrelintide demonstrated clinically meaningful weight loss through 42 weeks and was well tolerated among adults with obesity or overweight without diabetes, according to results from the phase 2…

Leggi questa versione → originale

Timeline cronologica

  1. domenica 7 giugno 2026·medpagetoday.com

    Modest Weight Loss Plus Few GI Upsets With Amylin Injectable

    Ideal weight-loss drug for primary care, patients without obesity-related complications

  2. lunedì 8 giugno 2026·healio.com

    Petrelintide, a novel amylin analog, induces 10% weight loss, very well tolerated

    NEW ORLEANS — Weekly petrelintide demonstrated clinically meaningful weight loss through 42 weeks and was well tolerated among adults with obesity or overweight without diabetes,…